Therapeutic Use of Intrathecal Mesenchymal Stem Cells in patients with Multiple Sclerosis: A Pilot Study with Booster Injection

Mohammad Ali Sahraian, Mandana Mohyeddin Bonab, Seyed Mohammad Baghbanian, Mahsa Owji, Abdorreza Naser Moghadasi

Immunological Investigations · 2018 · 34 citations · 11 references

Abstract

This study suggests that injection of MSC can be a suitable method, especially for secondary-progressive patients. It seems that reinjection of these stem cells can be safe and sustaining it positively increases the effects of this therapeutic approach.

References

11